Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Temporal shifts in iso/anisohydry revealed from daily observations of plant water potential in a dominant desert shrub.

Guo JS, Hultine KR, Koch GW, Kropp H, Ogle K.

New Phytol. 2020 Jan;225(2):713-726. doi: 10.1111/nph.16196. Epub 2019 Oct 28.

PMID:
31519032
2.

The Structure of an Archaeal B-Family DNA Polymerase in Complex with a Chemically Modified Nucleotide.

Kropp HM, Diederichs K, Marx A.

Angew Chem Int Ed Engl. 2019 Apr 8;58(16):5457-5461. doi: 10.1002/anie.201900315. Epub 2019 Mar 8.

PMID:
30761722
3.

Snapshots of a modified nucleotide moving through the confines of a DNA polymerase.

Kropp HM, Dürr SL, Peter C, Diederichs K, Marx A.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):9992-9997. doi: 10.1073/pnas.1811518115. Epub 2018 Sep 17.

4.

Understory vegetation mediates permafrost active layer dynamics and carbon dioxide fluxes in open-canopy larch forests of northeastern Siberia.

Loranty MM, Berner LT, Taber ED, Kropp H, Natali SM, Alexander HD, Davydov SP, Zimov NS.

PLoS One. 2018 Mar 22;13(3):e0194014. doi: 10.1371/journal.pone.0194014. eCollection 2018.

5.

Crystal structures of ternary complexes of archaeal B-family DNA polymerases.

Kropp HM, Betz K, Wirth J, Diederichs K, Marx A.

PLoS One. 2017 Dec 6;12(12):e0188005. doi: 10.1371/journal.pone.0188005. eCollection 2017.

6.

The diversity of experimental organisms in biomedical research may be influenced by biomedical funding.

Erick Peirson BR, Kropp H, Damerow J, Laubichler MD.

Bioessays. 2017 May;39(5). doi: 10.1002/bies.201600258. Epub 2017 Mar 30. Review.

PMID:
28370060
7.

Regioselective Cleavage of Thioether Linkages in Microcystin Conjugates.

Zemskov I, Kropp HM, Wittmann V.

Chemistry. 2016 Jul 25;22(31):10990-7. doi: 10.1002/chem.201601660. Epub 2016 Jun 27.

PMID:
27346324
8.

Coordination-induced spin-state change in manganese(V) complexes: the electronic structure of manganese(V) nitrides.

Kropp H, Scheurer A, Heinemann FW, Bendix J, Meyer K.

Inorg Chem. 2015 Apr 6;54(7):3562-72. doi: 10.1021/acs.inorgchem.5b00112. Epub 2015 Mar 26.

PMID:
25811888
9.

Seasonal stomatal behavior of a common desert shrub and the influence of plant neighbors.

Kropp H, Ogle K.

Oecologia. 2015 Feb;177(2):345-55. doi: 10.1007/s00442-014-3187-0. Epub 2014 Dec 20.

PMID:
25526845
10.

Pentacene appended to a TEMPO stable free radical: the effect of magnetic exchange coupling on photoexcited pentacene.

Chernick ET, Casillas R, Zirzlmeier J, Gardner DM, Gruber M, Kropp H, Meyer K, Wasielewski MR, Guldi DM, Tykwinski RR.

J Am Chem Soc. 2015 Jan 21;137(2):857-63. doi: 10.1021/ja510958k. Epub 2015 Jan 2.

PMID:
25478639
11.

PK modulation of haptenylated peptides via non-covalent antibody complexation.

Hoffmann E, Konkar A, Dziadek S, Josel HP, Conde-Knape K, Kropp H, Kling L, Stubenrauch K, Thorey I, Dengl S, Brinkmann U.

J Control Release. 2013 Oct 10;171(1):48-56. doi: 10.1016/j.jconrel.2013.06.021. Epub 2013 Jun 22.

12.

Manganese nitride complexes in oxidation states III, IV, and V: synthesis and electronic structure.

Kropp H, King AE, Khusniyarov MM, Heinemann FW, Lancaster KM, DeBeer S, Bill E, Meyer K.

J Am Chem Soc. 2012 Sep 19;134(37):15538-44. Epub 2012 Sep 6.

PMID:
22920682
13.

Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model.

Ernst EJ, Hashimoto S, Guglielmo J, Sawa T, Pittet JF, Kropp H, Jackson JJ, Wiener-Kronish JP.

Antimicrob Agents Chemother. 1999 Oct;43(10):2389-94.

15.

Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibiotic.

Rosen H, Hajdu R, Silver L, Kropp H, Dorso K, Kohler J, Sundelof JG, Huber J, Hammond GG, Jackson JJ, Gill CJ, Thompson R, Pelak BA, Epstein-Toney JH, Lankas G, Wilkening RR, Wildonger KJ, Blizzard TA, DiNinno FP, Ratcliffe RW, Heck JV, Kozarich JW, Hammond ML.

Science. 1999 Jan 29;283(5402):703-6.

16.

[An ophthalmologic image databank on the Internet].

Dick B, Wagner R, Schwenn O, Wassill H, Kropp H, Pfeiffer N.

Ophthalmologe. 1998 Jul;95(7):507-10. German.

PMID:
9738384
17.

In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345).

Gill CJ, Jackson JJ, Gerckens LS, Pelak BA, Thompson RK, Sundelof JG, Kropp H, Rosen H.

Antimicrob Agents Chemother. 1998 Aug;42(8):1996-2001.

18.

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872).

Hajdu R, Thompson R, Sundelof JG, Pelak BA, Bouffard FA, Dropinski JF, Kropp H.

Antimicrob Agents Chemother. 1997 Nov;41(11):2339-44.

19.

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis.

Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Pikounis VB, Balkovec JM, Bouffard AF, Dropinski JF, Rosen H, Kropp H, Bartizal K.

Antimicrob Agents Chemother. 1997 Nov;41(11):2333-8.

20.

Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primates.

Sundelof JG, Hajdu R, Gill CJ, Thompson R, Rosen H, Kropp H.

Antimicrob Agents Chemother. 1997 Aug;41(8):1743-8.

21.

Evaluation of experimental therapeutics in a new mouse model of Helicobacter felis utilizing 16S rRNA polymerase chain reaction for detection.

Smith JG, Kong L, Abruzzo GK, Gill CJ, Flattery AM, Scott PM, Silver L, Kropp H, Bartizal K.

Scand J Gastroenterol. 1997 Apr;32(4):297-302.

PMID:
9140149
22.

Pharmacokinetics in nonhuman primates of a prototype carbapenem active against methicillin-resistant Staphylococcus aureus.

Sundelof JG, Thompson R, White KM, Sasor MW, Cama L, Kropp H.

Antimicrob Agents Chemother. 1996 Mar;40(3):795-8.

23.

A sensitive and specific PCR method to detect Helicobacter felis in a conventional mouse model.

Kong L, Smith JG, Bramhill D, Abruzzo GK, Bonfiglio C, Cioffe C, Flattery AM, Gill CJ, Lynch L, Scott PM, Silver L, Thompson C, Kropp H, Bartizal K.

Clin Diagn Lab Immunol. 1996 Jan;3(1):73-8.

24.

In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.

Gill CJ, Abruzzo GK, Flattery AM, Smith JG, Jackson J, Kong L, Wilkening R, Shankaran K, Kropp H, Bartizal K.

J Antibiot (Tokyo). 1995 Oct;48(10):1141-7.

25.

Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis.

Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Krupa D, Pikounis VB, Kropp H, Bartizal K.

Antimicrob Agents Chemother. 1995 May;39(5):1077-81.

26.

In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373.

Bartizal K, Scott T, Abruzzo GK, Gill CJ, Pacholok C, Lynch L, Kropp H.

Antimicrob Agents Chemother. 1995 May;39(5):1070-6.

27.

Quantitative variations in beta-lactam antibiotic released endotoxin from Pseudomonas aeruginosa: in-vivo relevance.

Jackson JJ, Kropp H.

Prog Clin Biol Res. 1995;392:235-51. No abstract available.

PMID:
8524928
28.

Influence of antibiotic class and concentration on the percentage of release of lipopolysaccharide from Escherichia coli.

Jackson JJ, Kropp H, Hurley JC.

J Infect Dis. 1994 Feb;169(2):471-3. No abstract available.

PMID:
8106788
30.

Pharmacokinetics of L-671,329 in rhesus monkeys and DBA/2 mice.

Sundelof JG, Hajdu R, Cleare WJ, Onishi J, Kropp H.

Antimicrob Agents Chemother. 1992 Mar;36(3):607-10.

31.

Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP).

Balkovec JM, Black RM, Hammond ML, Heck JV, Zambias RA, Abruzzo G, Bartizal K, Kropp H, Trainor C, Schwartz RE, et al.

J Med Chem. 1992 Jan;35(1):194-8. No abstract available.

PMID:
1732529
32.

[Prevention of cytomegalic inclusion disease in leukemia patients with a cytomegalovirus hyperimmune globulin preparation].

Gerein V, Kropp H, Schwabe D, Gussetis E, Langer B, Kornhuber B.

Klin Padiatr. 1989 Jul-Aug;201(4):322-9. German.

PMID:
2550700
34.

Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanine.

Darland GK, Hajdu R, Kropp H, Kahan FM, Walker RW, Vandenheuvel WJ.

Drug Metab Dispos. 1986 Nov-Dec;14(6):668-73.

PMID:
2877824
35.

Antibacterial activity of imipenem: the first thienamycin antibiotic.

Kropp H, Gerckens L, Sundelof JG, Kahan FM.

Rev Infect Dis. 1985 Jul-Aug;7 Suppl 3:S389-410. Review.

PMID:
3931196
36.

Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.

Birnbaum J, Kahan FM, Kropp H, MacDonald JS.

Am J Med. 1985 Jun 7;78(6A):3-21.

PMID:
3859213
37.

Thienamycin: development of imipenen-cilastatin.

Kahan FM, Kropp H, Sundelof JG, Birnbaum J.

J Antimicrob Chemother. 1983 Dec;12 Suppl D:1-35. Review.

PMID:
6365872
38.

Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors.

Norrby SR, Alestig K, Björnegård B, Burman LA, Ferber F, Huber JL, Jones KH, Kahan FM, Kahan JS, Kropp H, Meisinger MA, Sundelof JG.

Antimicrob Agents Chemother. 1983 Feb;23(2):300-7.

39.

Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.

Kropp H, Sundelof JG, Hajdu R, Kahan FM.

Antimicrob Agents Chemother. 1982 Jul;22(1):62-70.

40.

[Varicella-zoster-immunoglobulin as a safe prophylaxis of varicella (author's transl)].

Kornhuber B, Kropp H, Ribeiro-Ayeh J, Hinderfeld L, Welte K.

Monatsschr Kinderheilkd. 1982 Jan;130(1):27-9. German.

PMID:
6278297
41.

MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.

Kropp H, Sundelof JG, Kahan JS, Kahan FM, Birnbaum J.

Antimicrob Agents Chemother. 1980 Jun;17(6):993-1000.

42.

[Prevention of varicella in children on immunosuppressive therapy (author's transl)].

Kornhuber B, Kropp H, Ribeiro-Ayeh J.

Klin Padiatr. 1980 Mar;192(2):154-6. German.

PMID:
7191452
43.

Use of acetylacetone to prepare a prodrug of cycloserine.

Jensen NP, Friedman JJ, Kropp H, Kahan FM.

J Med Chem. 1980 Jan;23(1):6-8.

PMID:
6987402
44.

[Clinical trials with mercapto polycytidylic acid in the treatment of acute childhood leukemia (author's transl)].

Kornhuber B, Chandra P, Kropp H.

Klin Padiatr. 1979 Mar;191(2):152-5. German.

PMID:
286846
46.

[Interstitial pneumonia in children on cystostatic treatment for malignant systematic disease (author's transl)].

Ball F, Schuster W, Ulmer EM, Kauschat I, Kropp H, Seiler G.

Rontgenblatter. 1975 Oct;28(10):443-54. German.

PMID:
1082626
47.

The mechanism of action of fosfomycin (phosphonomycin).

Kahan FM, Kahan JS, Cassidy PJ, Kropp H.

Ann N Y Acad Sci. 1974 May 10;235(0):364-86. No abstract available.

PMID:
4605290
48.

[Herpesvirus diseases in children with acute leukosis. Treatment with cytosine-arabinoside].

Gunkel U, Kropp H.

Fortschr Med. 1974 Mar 21;92(9):393-5. German. No abstract available.

PMID:
4362176
49.

[Abdominal neoplasms in childhood].

Kropp H, Kornhuber B.

Med Klin. 1973 Sep 14;68(37):1181-6. German. No abstract available.

PMID:
4356202
50.

Letter: New antibacterial agent via photofluorination of a bacterial cell wall constituent.

Kollonitsch J, Barash L, Kahan FM, Kropp H.

Nature. 1973 Jun 8;243(5406):346-7. No abstract available.

PMID:
4147634

Supplemental Content

Support Center